The antibiotic properties of pyrrolnitrin ( Fig.  1 ) produced by Pseudomonas pyrrocinia were first reported by Arima et al. (1) . Subsequently, Nishida et al. (7) described the antimicrobial activity of this antibiotic and showed that pyrrolnitrin was highly active against dermatophytes. Recently, our laboratory reported (3) the results of an extensive evaluation of the in vitro activity and in vivo effectiveness of topical treatments of this antibiotic against dermatophytes.
The purpose of this investigation was to evaluate the activity of this antibiotic against fungi responsible for deep-seated mycoses.
MATERIALS AND METHODS The in vitro susceptibility to pyrroinitrin was determined by the broth dilution test with Sabouraud's broth as modified by Emmons (2) . Siliconized glass tubes containing twofold dilutions of antibiotic in the medium were inoculated with a suspension prepared from homogenized fungal growth standardized at 30% transmittance at 660 nm. The inoculated tubes were placed in a Psychrotherm incubator at 37 C and were rotated on a rotary shaker at 200 rev/min. All determinations were made when tubes without pyrrolnitrin exhibited abundant growth. The minimal inhibitory concentration (MIC) forpyrrolnitrinwasrecorded as the lowest concentration of antibiotic which prevented visible growth. Tubes containing 5 ml of antibiotic-free broth were then inoculated with 0.05 1 Presented at the 68th Annual Meeting of the American Society for Microbiology, 5-10 May 1968, Detroit, Mich. ml from tubes in the MIC series not exhibiting visible growth to determine the minimal lethal concentration (MLC). The lack of visible growth in antibiotic-free broth after incubation indicated that the corresponding concentration of pyrrolnitrin in the MIC determination had a fungicidal effect. The lowest concentration of pyrrolnitrin producing this effect was the MLC.
Blood, urine, and tissue levels of pyrrolnitrin activity as well as the influence of sera on antibiotic activity were determined by microbiological assay using Neurospora crassa M45-846. The sensitivity of this agar diffusion assay was 0.1 ,ug/ml (R. S. Gordee and J. Westhead, submitted for publication). Experimental infections of all pathogenic fungi were acheived by injecting 0.1 ml of inoculum into the lateral tail vein of CD1 mice weighing 18 to 20 g. A total of 10 mice were infected for each concentration of antibiotic studied and for placebo controls GORDEE ANI nitrin may be metabolized at a rapid rate to a biologically inactive form or rapidly excreted from the animal. Therefore, a frequent multiple-treatment schedule was used to insure sustained quantities of free antibiotic in blood and tissues with relatively nontoxic doses.
The significant reduction in effectiveness of pyrrolnitrin against C. albicans A26 at 24 hr after treatment compared to 4-hr posttreatment indicates that pyrrolnitrin may have been fungistatic or that the fungal cells were not uniformly exposed to the antibiotic. Once antibiotic treatment stopped, the fungal cells not killed by pyrrolnitrin proliferated rapidly. Pyrrolnitrin was active in vivo against C. neoformans WS 34, however, 5-fluorocytosine was more effective at comparable doses of 15 mg/kg.
Pyrrolnitrin was ineffective against B. dermatitidis 6059 and H. capsulatum 26, whereas hamycin and saramycetin were highly effective against these fungi, respectively.
The necessity for frequent multiple doses of pyrrolnitrin for detectable blood and urine activity and the absence of outstanding efficacy against experimental deep-seated mycoses indicate that this antibiotic would have limited use as a systemic antifungal agent.
